Genomic risk prediction of complex human disease and its clinical application

Current Opinion in Genetics and Development

Volumn 33, Issue , 2015, Pages 10-16

  Abraham, Gad ^a   Inouye, Michael ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELIAC DISEASE; COST BENEFIT ANALYSIS; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SCREENING; GENOMICS; GENOTYPING TECHNIQUE; HEREDITY; HIGH THROUGHPUT SEQUENCING; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; CARDIOVASCULAR DISEASES; GENETIC DISORDER; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; PATHOLOGY; RISK FACTOR;

CARDIOVASCULAR DISEASES; CELIAC DISEASE; GENETIC DISEASES, INBORN; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; RISK FACTORS;

EID: 84937883029     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2015.06.005     Document Type: Review

References (55)

1. Trynka G., Hunt K., Bockett N., Romanos J., Mistry V., Szperl A., Bakker S.F., Bardella M.T., Bhaw-Rosun L., Castillejo G., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011, 43:1193-1201.
2. Dubois P.C.A., Trynka G., Franke L., Hunt K., Romanos J., Curtotti A., Zhernakova A., Heap G.R., Adány R., Aromaa A., et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010, 42:295-302.
3. Hunt K.A., Zhernakova A., Turner G., Heap G.A., Franke L., Bruinenberg M., Romanos J., Dinesen L.C., Ryan A.W., Panesar D., et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008, 40:395-402.
4. van Heel D.A., Franke L., Hunt K.A., Gwilliam R., Zhernakova A., Inouye M., Wapenaar M.C., Barnardo M.C.N.M., Bethel G., Holmes G.K.T., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007, 39:827-829.
5. The Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
6. Barrett J.C., Clayton D.G., Concannon P., Akolkar B., Cooper J.D., Erlich H.A., Julier C., Morahan G., Nerup J., Nierras C., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
7. Bradfield J.P., Qu H.Q., Wang K., Zhang H., Sleiman P.M., Kim C.E., Mentch F.D., Qiu H., Glessner J.T., Thomas K.A., et al. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet 2011, 7:e1002293.
8. CARDIoGRAMplusC4D Consortium, Deloukas P., Kanoni S., Willenborg C., Farrall M., Assimes T.L., Thompson J.R., Ingelsson E., Saleheen D., Erdmann J., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013, 45:25-33.
9. Astle W., Balding D.J. Population structure and cryptic relatedness in genetic association studies. Stat Sci 2009, 24:451-471.
10. Romanos J., Rosen A., Kumar V., Trynka G., Franke L., Szperl A., Gutierrez-Achury J., van Diemen C.C., Kanninga R., Jankipersadsing S.A., et al. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014, 63:415-422.
11. Abraham G., Tye-Din J.A., Bhalala O.G., Kowalczyk A., Zobel J., Inouye M. Accurate and robust genomic prediction of celiac disease using statistical learning. PLoS Genet 2014, 10:e1004137.
12. Abraham G., Kowalczyk A., Zobel J., Inouye M. Performance and robustness of penalized and unpenalized methods for genetic prediction of complex human disease. Genet Epidemiol 2013, 37:184-195.
13. Wei Z., Wang K., Qu H.-Q., Zhang H., Bradfield J., Kim C., Frackleton E., Hou C., Glessner J.T., Chiavacci R., et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet 2009, 5:e1000678.
14. Wray N.R., Yang J., Hayes B.J., Price A.L., Goddard M.E., Visscher P.M. Pitfalls of predicting complex traits from SNPs. Nat Rev Genet 2013, 14:507-515.
15. Golan D., Rosset S. Effective genetic-risk prediction using mixed models. Am J Hum Genet 2014, 95:383-393.
16. Evans D., Visscher P., Wray N. Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum Mol Genet 2009, 18:3525-3531.
17. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
18. Hill W.G., Goddard M.E., Visscher P.M. Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 2008, 4:e1000008.
19. Meuwissen T.H., Hayes B.J., Goddard M.E. Prediction of total genetic value using genome-wide dense marker maps. Genetics 2001, 157:1819-1829.
20. de Los Campos G., Hickey J.M., Pong-Wong R., Daetwyler H.D., Calus M.P. Whole-genome regression and prediction methods applied to plant and animal breeding. Genetics 2013, 193:327-345.
21. Gianola D., Rosa G.J. One hundred years of statistical developments in animal breeding. Annu Rev Anim Biosci 2014.
22. Abraham G., Kowalczyk A., Zobel J., Inouye M. SparSNP: Fast and memory-efficient analysis of all SNPs for phenotype prediction. BMC Bioinf 2012, 13:88.
23. Speed D., Balding D.J. MultiBLUP: improved SNP-based prediction for complex traits. Genome Res 2014, 24:1550-1557.
24. Hoggart C.J., Whittaker J.C., De Iorio M., Balding D.J. Simultaneous analysis of all SNPs in genome-wide and re-sequencing association studies. PLoS Genet 2008, 4:e1000130.
25. Kooperberg C., LeBlanc M., Obenchain V. Risk prediction using genome-wide association studies. Genet Epidemiol 2010, 34:643-652.
26. Wei Z., Wang W., Bradfield J., Li J., Cardinale C., Frackelton E., Kim C., Mentch F., Van Steen K., Visscher P.M., et al. Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet 2013, 1008-1012.
27. Wang J.H., Pappas D., De Jager P.L., Pelletier D., de Bakker P.I., Kappos L., Polman C.H., Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik L.B., et al. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med 2011, 3:3.
28. Yang J., Lee S.H., Goddard M.E., Visscher P.M. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011, 88:76-82.
29. Wray N.R., Yang J., Goddard M.E., Visscher P.M. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 2010, 6:e1000864.
30. Altman D.G., Bland J.M. Diagnostic tests 2: predictive values. Br Med J 1994, 309:102.
31. Dube C., Rostom A., Sy R., Cranney A., Saloojee N., Garritty C., Sampson M., Zhang L., Yazdi F., Mamaladze V., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005, 128:S57-S67.
32. van Heel D., West J. Recent advances in coeliac disease. Gut 2006, 55:1037-1046.
33. Mustalahti K., Catassi C., Reunanen A., Fabiani E., Heier M., McMillan S., Murray L., Metzger M.H., Gasparin M., Bravi E., et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010, 42:587-595.
34. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?. Gastroenterology 2005, 128:S25-S32.
35. Anderson R.P., Henry M.J., Taylor R., Duncan E.L., Danoy P., Costa M.J., Addison K., Tye-Din J.A., Kotowicz M.A., Knight R.E., et al. A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med 2013, 11:188.
36. Husby S., Koletzko S., Korponay-Szabo I.R., Mearin M.L., Phillips A., Shamir R., Troncone R., Giersiepen K., Branski D., Catassi C., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54:136-160.
37. Murch S., Jenkins H., Auth M., Bremner R., Butt A., France S., Furman M., Gillett P., Kiparissi F., Lawson M., et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child 2013, 98:806-811.
38. Romanos J., van Diemen C.C., Nolte I.M., Trynka G., Zhernakova A., Fu J., Bardella M.T., Barisani D., McManus R., van Heel D.A., et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009, 137(840):e831-e833. 834-40.
39. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet 2011, 13:135-145.
40. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
41. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2486-2497.
42. Goff D.C., Lloyd-Jones D.M., Bennett G., Coady S., D'Agostino R.B., Gibbons R., Greenland P., Lackland D.T., Levy D., O'Donnell C.J., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129:S49-S73.
43. Marma A.K., Lloyd-Jones D.M. Systematic examination of the updated Framingham heart study general cardiovascular risk profile. Circulation 2009, 120:384-390.
44. Mendis S., Puska P., Norrving B., World Health Organization, World Heart Federation, World Stroke Organization Global atlas on cardiovascular disease prevention and control 2011, World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, Geneva.
45. Tikkanen E., Havulinna A.S., Palotie A., Salomaa V., Ripatti S. Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease. Arterioscler Thromb Vasc Biol 2013, 33:2261-2266.
46. Ripatti S., Tikkanen E., Orho-Melander M., Havulinna A.S., Silander K., Sharma A., Guiducci C., Perola M., Jula A., Sinisalo J., et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet 2010, 376:1393-1400.
47. Havulinna A.S., Kettunen J., Ukkola O., Osmond C., Eriksson J.G., Kesaniemi Y.A., Jula A., Peltonen L., Kontula K., Salomaa V., et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 2013, 61:987-994.
48. Thanassoulis G., Peloso G.M., Pencina M.J., Hoffmann U., Fox C.S., Cupples L.A., Levy D., D'Agostino R.B., Hwang S.J., O'Donnell C.J. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet 2012, 5:113-121.
49. Ganna A., Magnusson P.K., Pedersen N.L., de Faire U., Reilly M., Arnlov J., Sundstrom J., Hamsten A., Ingelsson E. Multilocus genetic risk scores for coronary heart disease prediction. Arterioscler Thromb Vasc Biol 2013, 33:2267-2272.
50. Tada H., Shiffman D., Smith J.G., Sjogren M., Lubitz S.A., Ellinor P.T., Louie J.Z., Catanese J.J., Engstrom G., Devlin J.J., et al. Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke. Stroke 2014, 45:2856-2862.
51. Paynter N.P., Chasman D.I., Pare G., Buring J.E., Cook N.R., Miletich J.P., Ridker P.M. Association between a literature-based genetic risk score and cardiovascular events in women. J Am Med Assoc 2010, 303:631-637.
52. Ibrahim-Verbaas C.A., Fornage M., Bis J.C., Choi S.H., Psaty B.M., Meigs J.B., Rao M., Nalls M., Fontes J.D., O'Donnell C.J., et al. Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke 2014, 45:403-412.
53. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet 2013, 9:e1003348.
54. McBride C.M., Koehly L.M., Sanderson S.C., Kaphingst K.A. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?. Annu Rev Public Health 2010, 31:89-103.
55. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I., Shuldiner A.R., Knowler W.C., Nathan D.M., Altshuler D., Diabetes Prevention Program Research Group TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006, 355:241-250.